← Leaderboards
David Glenn McFadden
Massachusetts Institute Of Technology
$6,817,530
Attributed
$9,094,034
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $12.1M · FY2009–25$20M$15M$10M$5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,136,183 · 6
By mechanism
U54$12,060,540 · 2
UM1$4,553,009 · 1
R01$1,562,912 · 1
K08$900,320 · 1
F32$59,402 · 1
Top collaborators
- Joseph M Ready2 shared
- James F Amatruda1 shared
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- David M Nathan$156,869,844
- Christian T Farrar$64,203
- Li-Huei Tsai$66,135,710
- Joseph S Perkell$12,283,263
- Seth M Cohen$8,971,153
Others in their field
Top investigators on “Genetic”
- Richard A Gibbs · Baylor College Of Medicine$577,061,667
- Eric S Lander · Whitehead Institute For Biomedical Res$560,806,052
- David R. Weir · University Of Michigan At Ann Arbor$322,225,557
- Richard K. Wilson · Washington University$316,685,275
- Lawrence Corey · Fred Hutchinson Cancer Center$312,182,347
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$302,429,647
Research focus
GeneticCell LineTumorigenesisMalignant NeoplasmsMutantTumorMalignant Neoplasm Of ThyroidMutationCancer PatientCellsGenetically Engineered MouseCancer CellEnvironmentMediatingBaseGenesCrispr ScreenIn VivoMolecularMouse ModelImpairmentInhibitorBiochemicalAlleles
Grant awards (14)
Targeting transcriptional addiction in fusion-driven sarcoma$2,349,362
UM1 · FY2025 · CA · contact PI
Identifying metabolic dependencies in Hurthle cell carcinoma of the thyroid-Res 1$529,988
R01 · FY2025 · CA · contact PI
Targeting transcriptional addiction in fusion-driven sarcoma$2,203,647
UM1 · FY2024 · CA · contact PI
Identifying metabolic dependencies in Hurthle cell carcinoma of the thyroid-Res 1$503,309
R01 · FY2024 · CA · contact PI
Identifying metabolic dependencies in Hurthle cell carcinoma of the thyroid-Res 1$529,615
R01 · FY2023 · CA · contact PI
Targeting EWSR1-FLI1 through Functional, Structural and Chemical Approaches$10,042,149
U54 · FY2019 · CA · contact PI
Proteomic and Functional Genomic Interrogation of EWSR1-FLI1$2,018,391
U54 · FY2019 · CA · contact PI
"Comparative gene resequencing in mouse cancer models"$180,360
K08 · FY2015 · CA · contact PI
"Comparative gene resequencing in mouse cancer models"$143,248
K08 · FY2014 · CA · contact PI
"Comparative gene resequencing in mouse cancer models"$37,112
K08 · FY2014 · CA · contact PI
"Comparative gene resequencing in mouse cancer models"$180,360
K08 · FY2013 · CA · contact PI
"Comparative gene resequencing in mouse cancer models"$180,360
K08 · FY2012 · CA · contact PI
"Comparative gene resequencing in mouse cancer models"$178,880
K08 · FY2011 · CA · contact PI
Modelling BRaf-dependent thyroid cancer in the mouse$59,402
F32 · FY2009 · CA · contact PI